Sorrento CEO Henry Ji on How the Company Got Its Start
In this video from Motley Fool Live, which was recorded on Nov. 12, Henry Ji, chairman, president, and CEO of Sorrento Therapeutics (NASDAQ: SRNE), talks about how the biotech got its start. The company's focus on antibodies has helped it pivot from a previous focus on developing drugs for cancer and pain to tests, treatments, and vaccines for the COVID-19 pandemic.
Source Fool.com
